| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bad3312087281c5c1d021277dfa004 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 |
| filingDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff35300c0333aaf8c4317cdbe8c64bfc |
| publicationDate |
2003-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20030092449-A |
| titleOfInvention |
Composition comprising an extract of Zizania latifolia TURCZ. Inhibiting HCV activity |
| abstract |
The present invention uses the extract of Zizania latifolia TURCZ. To screen for inhibitors of the activity of hepatitis C virus-derived RNA-dependent RNA polymerase essential for the replication of hepatitis C virus (HCV) and to reduce cytotoxicity. Review and provide medicines and dietary supplements that are effective in the prevention and treatment of hepatitis C. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023287001-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115336756-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025185-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025185-B |
| priorityDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |